메뉴 건너뛰기
Clinical and Surgical Ophthalmology
Volumn 25, Issue 2, 2007, Pages 50-54
Combigan Early Experience Data Trial (CEED II): An in-depth look at the latest findings
Author keywords

[No Author keywords available]
Indexed keywords

EID: 33947175048     PISSN: 17054842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)
References (3)
  • 1
    • 33748596339 scopus 로고    scopus 로고
    • Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs. monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension. A 12-month randomized trial
    • Sherwood MB, Craven ER, Chou C, et al. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs. monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension. A 12-month randomized trial. Arch Ophthalmol 2006; 124: 1230-1238.
    • (2006) Arch Ophthalmol , vol.124 , pp. 1230-1238
    • Sherwood, M.B.1    Craven, E.R.2    Chou, C.3
  • 2
    • 27744509245 scopus 로고    scopus 로고
    • Timolol/brimonidine combination therapy in glaucoma management
    • Crichton ACS. Timolol/brimonidine combination therapy in glaucoma management. Clinical & Surgical Journal of Ophthalmology 2005; 23(10): 356-359.
    • (2005) Clinical & Surgical Journal of Ophthalmology , vol.23 , Issue.10 , pp. 356-359
    • Crichton, A.C.S.1
  • 3
    • 33749547830 scopus 로고    scopus 로고
    • A comparison of allergy rates in glaucoma patients receiving brimonidine monotherapy versus fixed combination brimonidine/timolol
    • Presented at the, March 2-5, Charleston, SC
    • Motolko MA, Crichton A. A comparison of allergy rates in glaucoma patients receiving brimonidine monotherapy versus fixed combination brimonidine/timolol. Presented at the American Glaucoma Society Annual Meeting, March 2-5, 2006; Charleston, SC.
    • (2006) American Glaucoma Society Annual Meeting
    • Motolko, M.A.1    Crichton, A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.